Related Experiment Video

Updated: Jun 16, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide

Lafayete William F Ramos1, Neif Murad, Eduardo Goto

  • 1Department of Medicine, Cardiology Division, Federal University of São Paulo (UNIFESP), Av. Macuco. 58/51, CEP: 04523000, São Paulo, SP, Brazil. lafayetewilliam@uol.com.br

Heart and Vessels
|January 29, 2010
PubMed

Insights

Ischemia/reperfusion significantly increases B-type natriuretic peptide (BNP) mRNA expression in the heart. This occurs independently of changes in ventricular volume or cardiomyocyte stretching, highlighting a direct molecular response to cardiac injury.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cardiac Ischemia Research

Background:

  • Myocardial B-type natriuretic peptide (BNP) is a key regulator of cardiovascular homeostasis.
  • BNP expression is typically associated with ventricular stretch, but its regulation during ischemia/reperfusion is not fully understood.
  • Investigating BNP mRNA expression independent of mechanical factors is crucial for understanding cardiac stress responses.

Purpose of the Study:

  • To determine if ischemia/reperfusion directly influences myocardial BNP mRNA expression.
  • To elucidate the role of BNP mRNA regulation independent of intracavitary diastolic volume and cardiomyocyte stretching.
  • To differentiate the effects of ischemia/reperfusion from mechanical stretch on BNP gene expression.

Main Methods:

  • Utilizing in situ and isolated heart models in rats subjected to controlled ischemia and reperfusion.
  • Quantifying myocardial B-type natriuretic peptide (BNP) mRNA expression using real-time polymerase chain reaction.
  • Implementing experimental designs to exclude or control for ventricular distension and cardiomyocyte stretching.

Main Results:

  • In situ hearts showed significantly elevated BNP mRNA in the ischemic region at 15 minutes of reperfusion compared to control and other time points.
  • Isolated hearts, perfused without ventricular distension, demonstrated higher BNP mRNA in ischemic regions than nonischemic regions.
  • These findings indicate that ischemia/reperfusion itself, not ventricular volume changes, drives increased BNP mRNA.

Conclusions:

  • Ischemia/reperfusion is a direct stimulus for increased myocardial BNP mRNA expression.
  • The observed increase in BNP mRNA is independent of mechanical stretch caused by altered ventricular diastolic volume.
  • This study reveals a direct molecular signaling pathway linking cardiac ischemia/reperfusion injury to BNP gene activation.

More Related Videos

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...